Literature DB >> 6143097

Lymphomas and lymphoproliferative lesions developing under cyclosporin therapy.

T Beveridge, P Krupp, C McKibbin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6143097     DOI： 10.1016/s0140-6736(84)91293-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  NonEBV-related B-cell lymphoma in a renal transplant patient responding to acyclovir and reduction in immunosuppression.

Authors:  R C Wong; P Harrison
Journal:  Postgrad Med J       Date:  1992-02       Impact factor: 2.401

Review 2.  Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders.

Authors:  T Haque; D H Crawford
Journal:  Springer Semin Immunopathol       Date:  1998

3.  Hematopoietic stem cell transplantation after posttransplant lymphoproliferative disorder.

Authors:  Min Joo Kim; Inho Kim; Hyun-Mi Bae; Kyungsuk Seo; Namjun Park; Sung-Soo Yoon; Seonyang Park; Byoung Kook Kim
Journal:  J Korean Med Sci       Date:  2010-04-16       Impact factor: 2.153

4.  Treatment of aplastic anemia with cyclosporin A, methylprednisolone, and antithymocyte globulin.

Authors:  N Frickhofen; W Heit; A Raghavachar; F Porzsolt; H Heimpel
Journal:  Klin Wochenschr       Date:  1986-11-17

5.  Cyclosporin A enhances locoregional metastasis of the CC531 rat colon tumour.

Authors:  W Van de Vrie; R L Marquet; A M Eggermont
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

6.  Intestinal Behçet's disease associated with non-Hodgkin's lymphoma.

Authors:  T Yamamoto; M Tamura; T Hamauzu; A Nakayama; K Kawasugi; M Kamakura; T Kinoshita; Y Kuyama; M Yamanaka; L M Wang; M Sanaka; S Mineshita
Journal:  J Gastroenterol       Date:  1997-04       Impact factor: 7.527

7.  Thymic and lymphoid changes and serum immunoglobulin abnormalities in mice receiving cyclosporine.

Authors:  A Hattori; H W Kunz; T J Gill; H Shinozuka
Journal:  Am J Pathol       Date:  1987-07       Impact factor: 4.307

8.  The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children.

Authors:  M Ho; R Jaffe; G Miller; M K Breinig; J S Dummer; L Makowka; R W Atchison; F Karrer; M A Nalesnik; T E Starzl
Journal:  Transplantation       Date:  1988-04       Impact factor: 4.939

9.  Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection.

Authors:  M Ho; G Miller; R W Atchison; M K Breinig; J S Dummer; W Andiman; T E Starzl; R Eastman; B P Griffith; R L Hardesty
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

Review 10.  Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders.

Authors:  Grace Y Lam; Brendan P Halloran; Anthea C Peters; Richard N Fedorak
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.